Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: keokalani'nui who wrote (7716)	1/12/2003 8:59:34 PM
From: Mike	Respond to of 52153

Wilder, Thank you very much for the response back on MDCO. I presume you were referring to The Medicine Company when you typed TMCO. There has been some very interesting discussion about the subset analysis that has been yet to be published on the Replace 2 trial. My sources tell me that the Replace 2 data will be published in JAMA in the next two weeks. Not sure if the JAMA publication will have the subsets analysis. If you do look further at the MDCO please let me know. It is a very interesting company with great growth prospects. In addition, I am trying to have a good "financial" person look at the "valuation" and fair value for MDCO. Thanks again for the reply, Mike